Xu Zhenyu 4
4 · SOPHiA GENETICS SA · Filed Apr 14, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CSO Zhenyu Xu Sells 8,120 Shares
What Happened
- Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA (SOPH), sold a total of 8,120 shares in mid-April 2026 for aggregate proceeds of approximately $38,374. The sales were executed on 2026-04-10 (3,706 shares at a weighted avg $4.68, ~$17,347) and 2026-04-13 (1,014 shares at $4.76, ~$4,830; and 3,400 shares at $4.76, ~$16,197). These were sales (not purchases) and represent routine dispositions rather than new acquisitions.
Key Details
- Transaction dates and reported amounts:
- 2026-04-10: 3,706 shares sold, weighted avg price $4.68, proceeds ~$17,347.
- 2026-04-13: 1,014 shares sold, weighted avg price $4.76, proceeds ~$4,830.
- 2026-04-13: 3,400 shares sold, weighted avg price $4.76, proceeds ~$16,197.
- Total sold: 8,120 shares for ~ $38,374.
- Shares owned after transaction: Not specified in the information provided in your summary of the filing.
- Footnotes / notable items:
- Sales were made pursuant to a pre-established Rule 10b5-1(c) trading plan and were to satisfy tax withholding obligations arising from restricted stock unit (RSU) vestings on April 2 and April 3, 2026.
- Reported prices are weighted averages; the filings state sales were executed across price ranges of $4.61–$4.77 and $4.63–$4.88 for the transactions. The reporting person will provide per-price breakdowns upon written request (per the footnotes).
- The Form 4 was filed on 2026-04-14; based on the transaction dates (April 10 and April 13) this filing appears timely under the two-business-day Form 4 rule.
Context
- These sales were tax-withholding dispositions tied to RSU vesting and executed under a pre-established 10b5-1 plan, which the filer states were non-discretionary. Such transactions are common for covering tax obligations and are generally viewed as routine rather than strong signals of insider sentiment.
Insider Transaction Report
Form 4
Xu Zhenyu
Chief Scientific Officer
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-04-10$4.68/sh−3,706$17,347→ 636,510 total - Sale
Ordinary Shares
[F1][F3]2026-04-13$4.76/sh−1,014$4,830→ 635,496 total - Sale
Ordinary Shares
[F4][F3]2026-04-13$4.76/sh−3,400$16,197→ 632,096 total
Footnotes (4)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.63 to $4.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
Signature
/s/ Elimara Brunetto as Attorney-in-fact for Zhenyu Xu|2026-04-14